🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
DELTA-2 is a phase 1 clinical trial to evaluate the safety, feasibility, an...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-08
Trial ID
NCT05393635
Treatments Being Tested
This is a prospective, multi-center, single-arm, phase 2 study aiming to as...
Status
Recruiting
Location
Jun Feng Liu
Start Date
2022-05-01
Trial ID
NCT05241028
Treatments Being Tested
This phase II trial studies how well onalespib works in treating patients w...
Status
Terminated
Location
Los Angeles County-USC Medical Center
Start Date
2016-04-04
Trial ID
NCT02572453
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled phase I...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2026-03-27
Trial ID
NCT07300514
Treatments Being Tested
This was a single-arm, open-label, multicenter, phase II study to evaluate ...
Status
Unknown
Location
Jilin Province Cancer Hospital
Start Date
2022-09
Trial ID
NCT05482087
Treatments Being Tested
This is a phase II, single arm, unblinded study of ceritinib in patients wi...
Status
Withdrawn
Location
Duke University Medical Center
Start Date
2015-05
Trial ID
NCT02343679
Treatments Being Tested
A Phase 2, multi center, open label, dual cohort study to evaluate the effi...
Status
Completed
Location
Gaoxin Hospital of The First Affilated Hospital of Anhui Medical University
Start Date
2019-04-28
Trial ID
NCT03909971
Treatments Being Tested
The primary goal of this study is to assess the safety and tolerability of ...
Status
Recruiting
Location
The Angeles Clinic and Research Institute
Start Date
2022-09-01
Trial ID
NCT05533697
Treatments Being Tested
A phase 3 study to evaluate the efficacy and safety of SY-3505 vs. crizotin...
Status
Not Yet Recruiting
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2024-05-01
Trial ID
NCT06254599
Treatments Being Tested
This non-randomized, open-label, multicenter study will evaluate the safety...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2013-09-30
Trial ID
NCT01871805
Treatments Being Tested